Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.4300 (-1.53%) ($26.0500 - $26.9400) on Fri. Jan. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.08% (three month average) | RSI | 29 | Latest Price | $26.4300(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.54% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.54% (StdDev 3.08%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
1 - 5 Day Possible Target | $16.79(-36.47%) | Resistance Level | $29.66 | 5 Day Moving Average | $27.46(-3.75%) | 10 Day Moving Average | $28.44(-7.07%) | 20 Day Moving Average | $29.66(-10.89%) | To recent high | -19.4% | To recent low | 29.6% | Market Cap | $1.641b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |